Literature DB >> 16209897

Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in mice.

Joe Inoue1, Satoshi Yotsumoto, Takatoshi Sakamoto, Seishi Tsuchiya, Yukihiko Aramaki.   

Abstract

CpG-oligodeoxynucleotide (CpG-ODN) plays a critical role in immunity via the augmentation of Th1 and suppression of Th2 responses. We examined here the effect of CpG-ODN on the immune response to an antigen applied to tape-stripped mouse skin by evaluating the production of cytokines and Ig isotypes. Confocal laser scanning microscopy revealed that the model antigen, OVA, and CpG-ODN easily penetrated the tape-stripped skin. Co-administration of CpG-ODN and OVA to the disrupted skin elicited an antigen-specific Th1-predominant immune response and enhanced the production of Th1-type cytokines, IL-12 and IFN-gamma. On the other hand, the production of a Th2-type cytokine, IL-4, was drastically suppressed. Cytokine production was supported by the expression of mRNA in the draining lymph node. In terms of antigen-specific antibody production, the level of IgG2a which is regulated by IFN-gamma was increased by CpG-ODN, but IgE production regulated by IL-4 was suppressed. Furthermore, administration of CpG-ODN via the skin drastically attenuated the production of IgE in mice undergoing IgE-type immune response. Administration of CpG-ODN through the skin may shift the immune response from Th2 to Th1-like response. These results suggested that administration of CpG-ODN via skin is a simple strategy for patients with diseases like AD, which is characterized by Th2-dominated inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209897     DOI: 10.1016/j.jconrel.2005.08.014

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  7 in total

1.  Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9.

Authors:  Cristiana Guiducci; Claudio Tripodo; Mei Gong; Sabina Sangaletti; Mario P Colombo; Robert L Coffman; Franck J Barrat
Journal:  J Exp Med       Date:  2010-11-29       Impact factor: 14.307

Review 2.  Skin as an immune organ and clinical applications of skin-based immunotherapy.

Authors:  J Andrew Bird; Mario Sánchez-Borges; Ignacio J Ansotegui; Motohiro Ebisawa; José Antonio Ortega Martell
Journal:  World Allergy Organ J       Date:  2018-12-07       Impact factor: 4.084

3.  Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery.

Authors:  Xingfang Su; Byeong-Su Kim; Sara R Kim; Paula T Hammond; Darrell J Irvine
Journal:  ACS Nano       Date:  2009-11-24       Impact factor: 15.881

4.  Noncytotoxic Inhibition of the Immunoproteasome Regulates Human Immune Cells In Vitro and Suppresses Cutaneous Inflammation in the Mouse.

Authors:  Marie Dominique Ah Kioon; Michael Pierides; Tania Pannellini; Gang Lin; Carl F Nathan; Franck J Barrat
Journal:  J Immunol       Date:  2021-03-05       Impact factor: 5.422

5.  Transcutaneous immunization system using a hydrotropic formulation induces a potent antigen-specific antibody response.

Authors:  Tomoka Takatani-Nakase; Erika Tokuyama; Megumi Komai; Koichi Takahashi
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

6.  Liposomal lipopolysaccharide initiates TRIF-dependent signaling pathway independent of CD14.

Authors:  Sachiko Watanabe; Yoshio Kumazawa; Joe Inoue
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

7.  Intracellular delivery of lipopolysaccharide induces effective Th1-immune responses independent of IL-12.

Authors:  Sachiko Watanabe; Joe Inoue
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.